The most differentially expressed ALD-HCC markers were upregulated CXCL13 and downregulated MIF; while NALFD-HCC was characterized by lower CXCL8 and higher circulating CXCL9 levels (Figure 3E,F). This evidence concerns the gene CXCL8 and hepatocellular carcinoma.